|
Press Releases |
|
|
|
Monday, March 18, 2024 |
|
亿胜生物公布2023年度业绩,收入增长29.5%,利润增长22.1% |
亿胜生物科技有限公司(「亿胜生物」或「集团」;股份代码:1061.HK)今日公布截至2023年12月31日止的年度财务业绩。 more info >> |
|
億勝生物公布2023年度業績,收入增長29.5%,利潤增長22.1% |
億勝生物科技有限公司(「億勝生物」或「集團」;股份代碼:1061.HK)今日公布截至2023年12月31日止的年度財務業績。 more info >> |
|
Essex Bio-Technology Posts Sound 2023 Annual Financial Results, Revenue Up 29.5%, Profit Up 22.1% |
Essex Bio-Technology Limited ("Essex" or the "Group", Stock Code: 1061.HK) today announced the annual results for the year ended 31 December 2023. more info >> |
|
Wednesday, August 16, 2023 |
|
亿胜生物公布2023年中期业绩 收入同比增长37.1% 净利润同比增长22.0% |
亿胜生物科技有限公司(「亿胜生物」或「集团」;股份代码:1061.HK)今日公布截至2023年6月30日止(「回顾期内」)的中期财务业绩。 more info >> |
|
億勝生物公佈2023年中期業績 收入同比增長37.1% 淨利潤同比增長22.0% |
億勝生物科技有限公司(「億勝生物」或「集團」;股份代碼:1061.HK)今日公佈截至2023年6月30日止(「回顧期內」)的中期財務業績。 more info >> |
|
Essex Bio-Technology Posts Sound 2023 Interim Financial Results, Revenue Up 37.1%, Profit Up 22% |
Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced the interim results for the six months ended 30 June 2023 ("the period under review"). more info >> |
|
Wednesday, July 26, 2023 |
|
亿胜生物宣布贝伐珠单抗眼科适应症I/II期临床研究成功完成 |
亿胜生物科技有限公司(「亿胜生物」或「集团」,股票代码:1061.HK)今日宣布,集团与上海复宏汉霖生物技术股份有限公司(「复宏汉霖」,股票代码:2696.HK)合作开发的重组抗血管内皮生长因子(Vascular endothelial growth factor, VEGF) more info >> |
|
億勝生物宣布貝伐珠單抗眼科適應症I/II期臨床研究成功完成 |
億勝生物科技有限公司(「億勝生物」或「集團」,股票代碼:1061.HK)今日宣布,集團與上海復宏漢霖生物技術股份有限公司(「復宏漢霖」,股票代碼:2696.HK)合作開發的重組抗血管內皮生長因子(Vascular endothelial growth factor, VEGF) more info >> |
|
The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed |
Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that a phase 1/2 clinical trial of EB12-20145P (HLX04-O), a recombinant anti-VEGF humanised monoclonal antibody injection jointly developed by the Group and Shanghai Henlius Biotech, Inc. more info >> |
|
Friday, April 14, 2023 |
|
亿胜生物与Osteopore签订口腔颌面产品在新加坡的独家代理协议 |
亿胜生物科技有限公司(“亿胜生物”或“集团”,股票代码:1061.HK)欣然宣布,集团全资附属子公司Majeton Pte. Ltd. ("Majeton")与Osteopore Limited ("Osteopore")达成合作,就Osteopore的牙科和口腔颌面产品("产品")签订独家代理协议。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Formerra Achieves ISCC PLUS Certification Across U.S. Warehouses, Enhancing Sustainable Material Distribution
May 8, 2024 22:00 HKT/SGT
|
|
|
Build4Asia 及亞洲零售論壇暨博覽會今日開幕
May 8, 2024 21:29 HKT/SGT
|
|
|
Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study
May 8, 2024 21:10 HKT/SGT
|
|
|
Build4Asia and Retail Asia Conference & Expo Kick Off Today
May 8, 2024 21:10 HKT/SGT
|
|
|
国美金融科技宣布拟收购游戏公司CashBox Group
May 8, 2024 21:04 HKT/SGT
|
|
|
國美金融科技宣佈擬收購遊戲公司CashBox Group
May 8, 2024 21:00 HKT/SGT
|
|
|
Indonesian BFSI IT Summit: Revolutionizing Finance Through Digital Transformation
May 8, 2024 17:12 HKT/SGT
|
|
|
Crypto Oasis Thrives: UAE Blockchain Ecosystem sees Exponential Growth with 2,040 Active Organizations in Q1 2024
May 8, 2024 17:00 HKT/SGT
|
|
|
Datacloud APAC: Charting the Course for APAC's Cloud Future
May 8, 2024 16:20 HKT/SGT
|
|
|
アフリカがついに日本のビジネスにおける国境を開放
May 8, 2024 15:00: JST
|
|
|
以数智化殡葬直面变化与挑战 福寿园国际集团组团参加2024AFE亚洲殡仪及墓园博览暨会议
May 8, 2024 14:05 HKT/SGT
|
|
|
以數智化殯葬直面變化與挑戰 福壽園國際集團組團參加2024AFE亞洲殯儀及墓園博覽暨會議
May 8, 2024 14:01 HKT/SGT
|
|
|
Mitsubishi Heavy Industries Increases Dividends on Back of Historically High FY2023 Results, Releases FY2024 Guidance
May 8, 2024 14:27 JST
|
|
|
Capital.com 的客戶交易量在2023年超過了1萬億美元
May 8, 2024 12:18 HKT/SGT
|
|
|
Capital.com的客户交易量在2023年超过了1万亿美元
May 8, 2024 12:12 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|